"Fluorescein Angiography" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Visualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. It is used especially in studying the retinal and uveal vasculature.
| Descriptor ID |
D005451
|
| MeSH Number(s) |
E01.370.370.050.350 E01.370.380.250
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fluorescein Angiography".
Below are MeSH descriptors whose meaning is more specific than "Fluorescein Angiography".
This graph shows the total number of publications written about "Fluorescein Angiography" by people in this website by year, and whether "Fluorescein Angiography" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 3 | 3 |
| 2004 | 0 | 3 | 3 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 5 | 5 |
| 2008 | 0 | 3 | 3 |
| 2009 | 1 | 1 | 2 |
| 2010 | 0 | 7 | 7 |
| 2011 | 0 | 3 | 3 |
| 2012 | 2 | 1 | 3 |
| 2013 | 1 | 5 | 6 |
| 2014 | 1 | 3 | 4 |
| 2015 | 2 | 5 | 7 |
| 2016 | 0 | 4 | 4 |
| 2017 | 2 | 6 | 8 |
| 2018 | 2 | 9 | 11 |
| 2019 | 4 | 9 | 13 |
| 2020 | 5 | 7 | 12 |
| 2021 | 3 | 14 | 17 |
| 2022 | 1 | 10 | 11 |
| 2023 | 0 | 10 | 10 |
| 2024 | 4 | 4 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fluorescein Angiography" by people in Profiles.
-
Risk factors for development of hyper-reflective foci overlying drusen in eyes with intermediate age-related macular degeneration. Br J Ophthalmol. 2024 Aug 22; 108(9):1234-1239.
-
Quantifying Geographic Atrophy in Age-Related Macular Degeneration: A Comparative Analysis Across 12 Deep Learning Models. Invest Ophthalmol Vis Sci. 2024 Jul 01; 65(8):42.
-
Oral Hypoxia-Inducible Factor 2a Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study. Ophthalmology. 2024 Nov; 131(11):1324-1332.
-
Treatment of Noninfectious Uveitic Macular Edema with Periocular and Intraocular Corticosteroid Therapies: A Report by the American Academy of Ophthalmology. Ophthalmology. 2024 Sep; 131(9):1107-1120.
-
Acquired Vitelliform Lesions in Intermediate Age-Related Macular Degeneration: A Cross Sectional Study. Ophthalmol Retina. 2024 Sep; 8(9):854-862.
-
Predictive Factors Influencing the Evolution of Acquired Vitelliform Lesions in Intermediate Age-Related Macular Degeneration Eyes. Ophthalmol Retina. 2024 Sep; 8(9):863-871.
-
Retinal non-perfusion: recognizing and defining what is important. Eye (Lond). 2024 Jun; 38(9):1608-1609.
-
Topographic analysis of local OCT biomarkers which predict progression to atrophy in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2024 Jul; 262(7):2083-2091.
-
Therapies for Geographic Atrophy. Int Ophthalmol Clin. 2024 Jan 01; 64(1):5-20.
-
Update on the Management of Central Serous Chorioretinopathy. Int Ophthalmol Clin. 2024 Jan 01; 64(1):179-193.